Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
193 studies found for:    "combined pituitary hormone deficiency" OR "Hypopituitarism"
Show Display Options
Rank Status Study
21 Completed Effect of 5 Years of GH Replacement on Atherosclerosis
Conditions: Hypopituitarism;   Pituitary Tumors;   Growth Hormone Deficiency
Intervention: Drug: Recombinant Growth Hormone, Genotropin (Pfizer)
22 Completed Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency;   Septo-Optic Dysplasia;   Hypopituitarism
Intervention: Drug: Nutropin AQ
23 Completed Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
Conditions: Secondary Hypothyroidism;   Hypopituitarism;   Hyperlipidemias
Intervention: Drug: Thyroxin, Triiodothyronine
24 Completed Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
Condition: Hypopituitarism
Intervention: Drug: Somatropin
25 Unknown  Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults
Condition: Hypopituitarism
Intervention: Drug: Human Growth hormone  - nutropin
26 Completed VRS-317 in Adult Subjects With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: VRS-317
27 Completed Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages
Conditions: Brain Injuries;   Intracranial Aneurysm
Intervention:
28 Active, not recruiting Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma
Condition: Craniopharyngioma
Intervention: Procedure: Different surgical approach and techniques being used to treat three subtype of CP
29 Completed Effect of Growth Hormone in Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children;   Growth Disorder;   Idiopathic Short Stature
Intervention: Drug: somatropin
30 Completed
Has Results
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Conditions: Idiopathic Growth Hormone Deficiency;   Turner Syndrome
Intervention: Other: Blood sampling
31 Recruiting Comparison of Long-acting Growth Hormone VRS-317 to Daily Growth Hormone in Pediatric GHD Patients
Condition: Growth Disorders
Interventions: Drug: VRS-317;   Drug: Daily rhGH
32 Completed Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Intervention: Drug: somatropin
33 Completed National Cooperative Growth Study in CKD
Condition: Growth Hormone Deficiency
Intervention:
34 Completed Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
Conditions: Growth Hormone Deficiency;   Growth Retardation
Intervention: Drug: Somatropin
35 Completed Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)
Condition: Growth Hormone Deficiency
Intervention: Drug: Norditropin SimpleXx (growth hormone)
36 Completed Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
Conditions: Acromegaly;   Growth Hormone Deficiency
Intervention:
37 Completed The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients
Condition: Growth Hormone Deficiency
Intervention: Drug: Pioglitazone
38 Active, not recruiting Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
Condition: Adult Growth Hormone Deficiency
Interventions: Drug: HM10560A;   Drug: Genotropin
39 Terminated
Has Results
Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
Condition: Growth Hormone Deficiency (GHD)
Intervention: Drug: Saizen®
40 Completed
Has Results
Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method
Condition: Growth Hormone Deficiency
Interventions: Device: T-jet® containing TevTropin®;   Procedure: TevTropin® needle-syringe injection method

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years